Inventor · disambiguated record
Punit P. Seth
Also filed as: SETH PUNIT · SETH PUNIT P
112 granted patents·76 pending applications·7,150 citations·filing 2002–2025
99Inventor score
Files withIONIS PHARMACEUTICALS INC119ISIS PHARMACEUTICALS INC30SETH PUNIT P14BHANOT SANJAY6ASTRAZENECA AB4
Top patents by PatentIndex Score
188 records- 0199US9181549B2Conjugated antisense compounds and their useISIS PHARMACEUTICALS INC·Filed 2014·Granted Nov 10, 2015·69 cites·30 claims
- 0299US9127276B2Conjugated antisense compounds and their useISIS PHARMACEUTICALS INC·Filed 2014·Granted Sep 8, 2015·136 cites·6 claims
- 0399US9005906B2Tetrahydropyran nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2014·Granted Apr 14, 2015·163 cites·24 claims
- 0499US8440803B2Tetrahydropyran nucleic acid analogsSWAYZE ERIC E·Filed 2011·Granted May 14, 2013·158 cites·16 claims
- 0599US8278283B26-disubstituted or unsaturated bicyclic nucleic acid analogsSETH PUNIT P·Filed 2008·Granted Oct 2, 2012·326 cites·44 claims
- 0699US8278426B2Carbocyclic bicyclic nucleic acid analogsSETH PUNIT P·Filed 2008·Granted Oct 2, 2012·323 cites·55 claims
- 0799US8268980B25′-modified bicyclic nucleic acid analogsSETH PUNIT P·Filed 2011·Granted Sep 18, 2012·182 cites·18 claims
- 0899US8030467B25′-modified bicyclic nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2010·Granted Oct 4, 2011·327 cites·26 claims
- 0999US8022193B26-modified bicyclic nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2010·Granted Sep 20, 2011·335 cites·19 claims
- 1099US7750131B25′-modified bicyclic nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2009·Granted Jul 6, 2010·202 cites·40 claims
- 1199US7741457B26-modified bicyclic nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2008·Granted Jun 22, 2010·542 cites·24 claims
- 1299US7666854B2Bis-modified bicyclic nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2008·Granted Feb 23, 2010·308 cites·68 claims
- 1399US7547684B25′-modified bicyclic nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2007·Granted Jun 16, 2009·413 cites·50 claims
- 1499US7399845B26-modified bicyclic nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2007·Granted Jul 15, 2008·1.1k cites·49 claims
- 1598US11299736B1Conjugated antisense compounds and their useIONIS PHARMACEUTICALS INC·Filed 2020·Granted Apr 12, 2022·3 cites·21 claims
- 1698US11236335B2Selective antisense compounds and uses thereofIONIS PHARMACEUTICALS INC·Filed 2020·Granted Feb 1, 2022·6 cites·24 claims
- 1798US9617540B2Compounds and methods for modulating gene expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Apr 11, 2017·26 cites·20 claims
- 1898US9181550B2Compositions and methods for modulating apolipoprotein (a) expressionISIS PHARMACEUTICALS INC·Filed 2014·Granted Nov 10, 2015·16 cites·26 claims
- 1998US9163239B2Compositions and methods for modulating apolipoprotein C-III expressionISIS PHARMACEUTICALS INC·Filed 2014·Granted Oct 20, 2015·20 cites·26 claims
- 2098US9145558B2Compositions and methods for modulating HBV expressionISIS PHARMACEUTICALS INC·Filed 2015·Granted Sep 29, 2015·13 cites·24 claims
- 2198US9045754B2Short antisense compounds with gapmer configurationBHANOT SANJAY·Filed 2007·Granted Jun 2, 2015·56 cites·44 claims
- 2298US8993738B2Modified nucleosides, analogs thereof and oligomeric compounds prepared therefromPRAKASH THAZHA P·Filed 2011·Granted Mar 31, 2015·53 cites·19 claims
- 2398US8796437B2Tetrahydropyran nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2013·Granted Aug 5, 2014·85 cites·23 claims
- 2498US8546556B2Carbocyclic alpha-L-bicyclic nucleic acid analogsSETH PUNIT P·Filed 2008·Granted Oct 1, 2013·249 cites·32 claims
- 2598US8530640B2Bicyclic cyclohexitol nucleic acid analogsSETH PUNIT P·Filed 2009·Granted Sep 10, 2013·229 cites·42 claims
- 2698US8501805B2Substituted alpha-L-bicyclic nucleosidesSETH PUNIT P·Filed 2009·Granted Aug 6, 2013·252 cites·32 claims
- 2798US8088904B2Tetrahydropyran nucleic acid analogsSWAYZE ERIC E·Filed 2008·Granted Jan 3, 2012·164 cites·30 claims
- 2898US8088746B2Bis-modified bicyclic nucleic acid analogsSETH PUNIT P·Filed 2010·Granted Jan 3, 2012·175 cites·26 claims
- 2998US7569686B1Compounds and methods for synthesis of bicyclic nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2007·Granted Aug 4, 2009·501 cites·26 claims
- 3097US11851655B2Compositions and methods for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Dec 26, 2023·3 cites·33 claims
- 3197US10844379B2Conjugated antisense compounds and their useIONIS PHARMACEUTICALS INC·Filed 2018·Granted Nov 24, 2020·8 cites·20 claims
- 3297US9957504B2Compositions and methods for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted May 1, 2018·8 cites·56 claims
- 3397US9321799B2Modified nucleosides, analogs thereof and oligomeric compounds prepared therefromIONIS PHARMACEUTICALS INC·Filed 2015·Granted Apr 26, 2016·17 cites·24 claims
- 3497US9012421B2Bicyclic cyclohexose nucleic acid analogsMIGAWA MICHAEL T·Filed 2010·Granted Apr 21, 2015·182 cites·29 claims
- 3597US8143230B2Compounds and methods for modulating expression of PCSK9BHANOT SANJAY·Filed 2007·Granted Mar 27, 2012·44 cites·46 claims
- 3696US11149264B2Modified compounds and uses thereofIONIS PHARMACEUTICALS INC·Filed 2021·Granted Oct 19, 2021·5 cites·29 claims
- 3796US10883104B2Compositions and methods for modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2018·Granted Jan 5, 2021·5 cites·6 claims
- 3896US10683499B2Compositions and methods for modulating TTR expressionIONIS PHARMACEUTICALS INC·Filed 2017·Granted Jun 16, 2020·5 cites·53 claims
- 3996US9932580B2Compositions and methods for modulating HBV expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Apr 3, 2018·5 cites·42 claims
- 4096US9932581B2Compositions and methods for modulating apolipoprotein C-III expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Apr 3, 2018·6 cites·50 claims
- 4196US9695418B2Oligomeric compounds comprising bicyclic nucleosides and uses thereofIONIS PHARMACEUTICALS INC·Filed 2013·Granted Jul 4, 2017·36 cites·17 claims
- 4296US2025346899A1Conjugated antisense compounds and their useIONIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4395US11084844B2Modified nucleosides, analogs thereof and oligomeric compounds prepared therefromIONIS PHARMACEUTICALS INC·Filed 2018·Granted Aug 10, 2021·8 cites·20 claims
- 4495US10087210B2Modified nucleosides, analogs thereof and oligomeric compounds prepared therefromIONIS PHARMACEUTICALS INC·Filed 2016·Granted Oct 2, 2018·39 cites·9 claims
- 4595US9714421B2Compositions and methodsIONIS PHARMACEUTICALS INC·Filed 2014·Granted Jul 25, 2017·5 cites·17 claims
- 4695US8846637B2Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefromSETH PUNIT P·Filed 2011·Granted Sep 30, 2014·21 cites·36 claims
- 4795US8604192B2Cyclohexenyl nucleic acids analogsSETH PUNIT P·Filed 2009·Granted Dec 10, 2013·13 cites·15 claims
- 4895US8188059B2Compounds and methods for modulating expression of GCGRBHANOT SANJAY·Filed 2007·Granted May 29, 2012·22 cites·36 claims
- 4994US12509684B2Compositions and methods for modulating apolipoprotein C-III expressionIONIS PHARMACEUTICALS INC·Filed 2024·Granted Dec 30, 2025·0 cites·20 claims
- 5094US11732261B2Selective antisense compounds and uses thereofIONIS PHARMACEUTICALS INC·Filed 2020·Granted Aug 22, 2023·2 cites·20 claims
Showing the top 50 of 188 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →